Cargando…
Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response
The treatment and management of patients with metastatic melanoma have evolved considerably in the “era” of personalized medicine. Melanoma was one of the first solid tumors to benefit from immunotherapy; life expectancy for patients in advanced stage of disease has improved. However, many progresse...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067863/ https://www.ncbi.nlm.nih.gov/pubmed/33917181 http://dx.doi.org/10.3390/ijms22083837 |